CN110302113A - One kind is crease-resistant to remove black eye eye cream - Google Patents
One kind is crease-resistant to remove black eye eye cream Download PDFInfo
- Publication number
- CN110302113A CN110302113A CN201910719840.6A CN201910719840A CN110302113A CN 110302113 A CN110302113 A CN 110302113A CN 201910719840 A CN201910719840 A CN 201910719840A CN 110302113 A CN110302113 A CN 110302113A
- Authority
- CN
- China
- Prior art keywords
- eye
- eye cream
- crease
- cream
- calculated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006071 cream Substances 0.000 title claims abstract description 48
- 235000002673 Dioscorea communis Nutrition 0.000 title claims abstract description 29
- 241000544230 Dioscorea communis Species 0.000 title claims abstract description 29
- 208000035753 Periorbital contusion Diseases 0.000 title claims abstract description 29
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 27
- RTIXKCRFFJGDFG-UHFFFAOYSA-N chrysin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=CC=C1 RTIXKCRFFJGDFG-UHFFFAOYSA-N 0.000 claims abstract description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 17
- 150000001875 compounds Chemical class 0.000 claims abstract description 11
- 235000004347 Perilla Nutrition 0.000 claims abstract description 10
- BYUQATUKPXLFLZ-UIOOFZCWSA-N CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(O)=O)CC1=CN=CN1 Chemical compound CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(O)=O)CC1=CN=CN1 BYUQATUKPXLFLZ-UIOOFZCWSA-N 0.000 claims abstract description 9
- 229940041514 candida albicans extract Drugs 0.000 claims abstract description 9
- 239000003292 glue Substances 0.000 claims abstract description 9
- 229940093441 palmitoyl oligopeptide Drugs 0.000 claims abstract description 9
- -1 palmityl tetrapeptide -7 Chemical compound 0.000 claims abstract description 9
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 9
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 9
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims abstract description 9
- 239000012138 yeast extract Substances 0.000 claims abstract description 9
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims abstract description 8
- 229920002498 Beta-glucan Polymers 0.000 claims abstract description 8
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229920002385 Sodium hyaluronate Polymers 0.000 claims abstract description 8
- 108010006338 acetyl-glutamyl-glutamyl-methionyl-glutaminyl-arginyl-argininamide Proteins 0.000 claims abstract description 8
- 229940010747 sodium hyaluronate Drugs 0.000 claims abstract description 8
- RJZNPROJTJSYLC-LLINQDLYSA-N (4s)-4-acetamido-5-[[(2s)-1-[[(2s)-1-[[(2s)-5-amino-1-[[(2s)-1-[[(2s)-1-amino-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-car Chemical compound OC(=O)CC[C@H](NC(C)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O RJZNPROJTJSYLC-LLINQDLYSA-N 0.000 claims abstract description 7
- 244000124853 Perilla frutescens Species 0.000 claims abstract 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 12
- 239000004909 Moisturizer Substances 0.000 claims description 7
- 239000003974 emollient agent Substances 0.000 claims description 7
- 239000003995 emulsifying agent Substances 0.000 claims description 7
- 230000001333 moisturizer Effects 0.000 claims description 7
- 239000002904 solvent Substances 0.000 claims description 7
- 239000002562 thickening agent Substances 0.000 claims description 7
- MXOAEAUPQDYUQM-QMMMGPOBSA-N (S)-chlorphenesin Chemical group OC[C@H](O)COC1=CC=C(Cl)C=C1 MXOAEAUPQDYUQM-QMMMGPOBSA-N 0.000 claims description 6
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 claims description 6
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 6
- 241000220317 Rosa Species 0.000 claims description 6
- 235000018936 Vitellaria paradoxa Nutrition 0.000 claims description 6
- 241001135917 Vitellaria paradoxa Species 0.000 claims description 6
- 125000003118 aryl group Chemical group 0.000 claims description 6
- 229960003993 chlorphenesin Drugs 0.000 claims description 6
- 229920001577 copolymer Polymers 0.000 claims description 6
- 239000008367 deionised water Substances 0.000 claims description 6
- 229910021641 deionized water Inorganic materials 0.000 claims description 6
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 claims description 6
- 229940119170 jojoba wax Drugs 0.000 claims description 6
- 239000010466 nut oil Substances 0.000 claims description 6
- 235000019488 nut oil Nutrition 0.000 claims description 6
- 229960005323 phenoxyethanol Drugs 0.000 claims description 6
- 239000003755 preservative agent Substances 0.000 claims description 6
- 230000002335 preservative effect Effects 0.000 claims description 6
- 229940057910 shea butter Drugs 0.000 claims description 6
- 229920005573 silicon-containing polymer Polymers 0.000 claims description 6
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 4
- 235000009508 confectionery Nutrition 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 239000003921 oil Substances 0.000 claims description 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 2
- 125000003647 acryloyl group Chemical group O=C([*])C([H])=C([H])[H] 0.000 claims description 2
- 238000002242 deionisation method Methods 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 235000019198 oils Nutrition 0.000 claims description 2
- GDSOZVZXVXTJMI-SNAWJCMRSA-N (e)-1-methylbut-1-ene-1,2,4-tricarboxylic acid Chemical compound OC(=O)C(/C)=C(C(O)=O)\CCC(O)=O GDSOZVZXVXTJMI-SNAWJCMRSA-N 0.000 claims 1
- 239000000284 extract Substances 0.000 claims 1
- 239000003205 fragrance Substances 0.000 claims 1
- 229920000570 polyether Polymers 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 17
- 230000005808 skin problem Effects 0.000 abstract description 4
- 230000002195 synergetic effect Effects 0.000 abstract description 3
- 206010040954 Skin wrinkling Diseases 0.000 description 10
- 230000037303 wrinkles Effects 0.000 description 9
- 241000229722 Perilla <angiosperm> Species 0.000 description 6
- 230000003712 anti-aging effect Effects 0.000 description 4
- 230000004118 muscle contraction Effects 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 3
- 230000009759 skin aging Effects 0.000 description 3
- DOUMFZQKYFQNTF-WUTVXBCWSA-N (R)-rosmarinic acid Chemical compound C([C@H](C(=O)O)OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-WUTVXBCWSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000033764 rhythmic process Effects 0.000 description 2
- AJLNZWYOJAWBCR-OOPVGHQCSA-N (4s)-4-acetamido-5-[[(2s)-1-[[(2s)-1-[[(2s)-5-amino-1-[[(2s)-1-[[(2s)-1-amino-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-car Chemical compound OC(=O)CC[C@H](NC(C)=O)C(=C)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O AJLNZWYOJAWBCR-OOPVGHQCSA-N 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 208000001126 Keratosis Diseases 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 241001396014 Priacanthus arenatus Species 0.000 description 1
- ZZAFFYPNLYCDEP-HNNXBMFYSA-N Rosmarinsaeure Natural products OC(=O)[C@H](Cc1cccc(O)c1O)OC(=O)C=Cc2ccc(O)c(O)c2 ZZAFFYPNLYCDEP-HNNXBMFYSA-N 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical group [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 102000006612 Transducin Human genes 0.000 description 1
- 108010087042 Transducin Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 229940095094 acetyl hexapeptide-8 Drugs 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000007596 consolidation process Methods 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 229940035423 ethyl ether Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 125000000018 nitroso group Chemical group N(=O)* 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- DOUMFZQKYFQNTF-MRXNPFEDSA-N rosemarinic acid Natural products C([C@H](C(=O)O)OC(=O)C=CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-MRXNPFEDSA-N 0.000 description 1
- TVHVQJFBWRLYOD-UHFFFAOYSA-N rosmarinic acid Natural products OC(=O)C(Cc1ccc(O)c(O)c1)OC(=Cc2ccc(O)c(O)c2)C=O TVHVQJFBWRLYOD-UHFFFAOYSA-N 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000036555 skin type Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Dermatology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
Abstract
Crease-resistant black eye eye cream is removed the invention discloses a kind of; include following component: removing eye pouch compound HALOXYL (water, glycerol, stereth -20, n-hydroxysuccinimide, 5,7-dihydroxyflavone, palmitoyl oligopeptide, palmityl tetrapeptide -7), extractive of perilla, Argireline, 3-o- ethylascorbyl, yeast extract, silk glue protein, beta glucan and Sodium Hyaluronate.Under the synergistic effect of these components, eye cream of the invention have effects that it is excellent it is crease-resistant go black eye, skin lines can be improved, mitigate the skin problems such as black eye, eye pouch.
Description
Technical field
The present invention relates to cosmetic field, it is specifically related to a kind of crease-resistant remove black eye eye cream and preparation method thereof.
Background technique
Eye cream, one of skin type cosmetic product have moist effect, other than it can lower black eye, eye pouch problem, simultaneously
Also has the effect of improving wrinkle, microgroove.Eye cream has certain effectiveness to eye pouch, black eye, crow's feet etc., but is different
Eye cream plays the role of different.There are many type of eye cream, are functionally divided into moist eye cream, consolidation eye cream, moisturizing eye cream, anti-aging
Eye cream, antiallergic eye cream etc..
In recent years, with the progress and development of society, present people's lives rhythm is getting faster, the life of modern
Rhythm is generally accelerated, especially young man, stays up late for work, and fights by torchlight, just homely food, the bad habit of long-term work and rest
It is used, so as to cause the quickening of skin aging, so the problem of black eye, the skin problem of big eye pouch are at a generality,
Therefore, solve the problems, such as that the eye product of eye skin also can gradually become the favorite in market.
The eye cream that existing eye cream on the market is commonly simple function is in the majority, without in view of technicality is for anti-
It declines and is gone in conjunction with this three major issues of eye pouch with black eye is gone.
Summary of the invention
Solve above-mentioned shortcoming and defect existing in the prior art, the present invention, which provides, a kind of crease-resistant removes black eye eye cream.This
Goal of the invention is achieved through the following technical solutions:
It is a kind of it is crease-resistant removes black eye eye cream, it includes go eye pouch compound HALOXYL (water, glycerol, stereth -20,
N-hydroxysuccinimide, 5,7- dihydroxyflavone, palmitoyl oligopeptide, palmityl tetrapeptide -7), extractive of perilla, acetyl group six
Peptide -8,3-o- ethylascorbyl, yeast extract, silk glue protein, beta glucan, Sodium Hyaluronate.Remove eye pouch compound
HALOXYL is the raw material of sederma company, France production.This raw material is by water, glycerol, stereth -20, N- hydroxysuccinimidyl acyl
Imines, 5,7-dihydroxyflavone, palmitoyl oligopeptide, palmityl tetrapeptide -7), compound, go eye pouch compound HALOXYL can
Pigmentation is reduced, the linked groups of circumference of eyes fragility are rebuild, anti-inflammatory effect reduces vasodilation, and the final capillary that reduces is let out
Leakage, to dispel black eye；Extractive of perilla, there is superoxides to remove and live for the Rosmarinic acid of rich content in extractive of perilla
Property, there is certain removing free radical, prevent liposome peroxidation, block nitroso by substance biological effect, it is anti-to skin
Aging is crease-resistant unique meaning；Argireline, this is the polypeptide inside a kind of extensive use and anti-ageing product, it can subtract
The expression line that few skin surface is formed by contraction of muscle, contraction of muscle form wrinkle, and contraction of muscle is because having received nerve
The signal of transducin causes.For neurotransmitter from the secretion of capsule, acetyl hexapeptide -8 prevents vesica from being released effectively neural biography
Element is led, to reduce contraction of muscle, achievees the purpose that mitigate wrinkle, allows muscle naturally to move and express, also do not generate it
Its side effect；3-o- ethylascorbyl, 3-o- ethylascorbyl are also known as VC ethylether, are that there is ascorbic one kind to spread out
Biology has excellent anti-oxidant free radical resisting effect as Victoria C；Yeast extract, being capable of delay skin aging, acceleration
Epidermal cell repairing, anti-oxidant, removing free radical, promotes collagen synthesis, smoothes away wrinkles；Silk glue protein, can rapidly with
Cell surface combines, and extraneous growth signals are transmitted to the proliferation for directly facilitating tissue into the cell, reconstruction and reparation in time, and
It can be made by synergistic effects such as the generation of sericine free radical resisting, the pathology phagocytosis of inhibition zooblast and protection skins
Skin elasticity is centainly restored with plumpness, is generated and is eliminated wrinkle of skin, increases the effects of elasticity and anti aging effect；β-Portugal
The combination of glycan and cell-membrane receptor causes a series of spatial chemistry to change, and so as to cause activating macrophage, generates various thin
The generation of collagen and elastin laminin can be improved in intracellular cytokine, the increase of epithelical cell growth factor, closely makes the outer of skin
Sight is improved, and tiny wrinkle is made to disappear；Sodium Hyaluronate, can deep moisturizing, repair damaged cell, remove freely
Base has anti-ageing anti-wrinkle effect, and applicant compares the various combination mode of this eight kinds of components, as a result, it has been found that, in the presence of eight kinds of groups
Grouping is when being combined, and has obvious synergistic function between them, so that eye cream of the present invention is with relatively good
It is crease-resistant to go black eye effect.
The present invention is realized particular by following technical scheme:
Preferably, it is calculated by mass percentage, the eye cream removes eye pouch compound HALOXYL comprising 0.1%-5%'s
(water, glycerol, stereth -20, n-hydroxysuccinimide, 5,7- dihydroxyflavone, palmitoyl oligopeptide, palmityl tetrapeptide -
7), 0.1%-5% extractive of perilla, 0.1%-5% Argireline, 0.1%-2%3-o- ethylascorbyl, 0.1%-
5% yeast extract, 0.1%-5% silk glue protein, 0.02%-0.1% beta glucan and 0.02%-0.2% hyaluronic acid
Sodium.Studies have shown that under the described conditions, the crease-resistant of eye cream of the present invention goes black eye effect relatively good.
It is further preferred that be calculated by mass percentage, the Essence includes 3% to remove eye pouch compound
HALOXYL (water, glycerol, stereth -20, n-hydroxysuccinimide, 5,7- dihydroxyflavone, palmitoyl oligopeptide, palm
Acyl tetrapeptide -7), 2.5% extractive of perilla, 2.5% Argireline, 1.5%3-o- ethylascorbyl, 2% yeast extract
Object, 2.5% silk glue protein, 0.05% beta glucan and 0.1% Sodium Hyaluronate.Studies have shown that under the specified conditions,
Eye cream of the invention is crease-resistant to go black eye effect more preferable.
As the preferred embodiment of eye cream of the present invention, the eye cream also include moisturizer, emollient, emulsifier,
Thickener, preservative, aromatic and solvent.Moisturizer and emollient can make keratoderma keep wet, be conducive to effect
The absorption of ingredient；It is scattered that emulsifier can make other aqueous materials of oiliness emollient and system form stable water-oil milkiness midnight
System；Thickener can allow eye cream of the invention consistency with higher, to form the cream state without mobility；Preservative
The growth that can prevent microorganism is conducive to the storage of eye cream of the invention；Aromatic can make eye cream good smell of the invention,
Promoted user experience sense by；Solvent is used to dissolve various functional components.
As the preferred embodiment of eye cream of the present invention, the moisturizer include butanediol, 1.3- propylene glycol, gather it is sweet
Oil -10, the emollient is jojoba oil, shea butter, macadimia nut oil, emulsifier described in dimethyl silicone polymer be gather it is sweet
Oily -3 methyl distearates, the thickener are hydroxy-ethyl acrylate/sodium acryloyldimethyl taurate copolymers, institute
Stating preservative is Chlorphenesin and Phenoxyethanol, and the aromatic is attar of rose, and the solvent is deionized water.
It as the preferred embodiment of eye cream of the present invention, is calculated by mass percentage, the eye cream includes 1%-
10% moisturizer, the emollient of 1%-10%, 0.5%-2% emulsifier, 0.5%-2% thickener, 0.5%-1% anti-corrosion
The solvent deionized water of agent, 0.01%-0.1% aromatic and surplus.
It as the preferred embodiment of Essence of the present invention, is calculated by mass percentage, the eye cream includes 1%-
5% butanediol, 1%-5%1.3- propylene glycol, 1%-3% Natrulon H-10,1%-3% jojoba oil, 1%-3% shea butter,
1%-3% macadimia nut oil, 1%-3% dimethyl silicone polymer, 0.5%-2% polyglycereol-3-methyl distearate,
0,5%-2% hydroxy-ethyl acrylate/sodium acryloyldimethyl taurate copolymers, 0.1%-0.5% Chlorphenesin, 0.1%-
The deionized water of 0.5% Phenoxyethanol, 0.01%-0.1% attar of rose and surplus.
It as the preferred embodiment of eye cream of the present invention, is calculated by mass percentage, the eye cream includes 3% fourth two
Alcohol, 2%1.3- propylene glycol, 2% Natrulon H-10,1.5% jojoba oil, 1.5% shea butter, 1.5% macadimia nut oil,
1.5% dimethyl silicone polymer, 1.5% polyglycereol-3-methyl distearate, 1% hydroxy-ethyl acrylate/acryloyl two
N-methyltaurine sodium copolymer, 0.25% Chlorphenesin, 0.5% Phenoxyethanol, 0.03% attar of rose and surplus deionization
Water.
The advantages and benefits of the present invention are: eye cream of the present invention by will go eye pouch compound HALOXYL (water, glycerol,
Stereth -20, n-hydroxysuccinimide, 5,7- dihydroxyflavone, palmitoyl oligopeptide, palmityl tetrapeptide -7) purple perilla mentions
Take object, Argireline, 3-o- ethylascorbyl, yeast extract, silk glue protein, beta glucan and Sodium Hyaluronate
Combination and have effects that it is excellent it is crease-resistant go black eye, skin lines, the skin problems such as mitigation black eye, eye pouch can be improved.
Specific embodiment
Purposes, technical schemes and advantages in order to better illustrate the present invention, below with reference to embodiment to the present invention do into
One step illustrates:
Embodiment 1-5
Embodiment 1-4 is a kind of crease-resistant embodiment for removing black eye eye cream of the present invention, and implementing 5 is blank control example, tool
Body composition such as the following table 1:
Table 1
Efficacy validation:
1, subjects:
Choosing has different degrees of black-eyed patient 360, and men and women is fifty-fifty, and the age at 20 years old~55 years old, is randomly divided into 6 groups,
Every group of 60 people.
2, test products:
1~embodiment of embodiment 6 is smeared respectively for every group.
3, application method:
This product, is gently applied under brow ridge and eye, and pressed back and forth with index finger by thoroughly cleaning face skin with the third finger
Rub eye, smears see using effect with after 2~3 times, one month daily.
4, efficacy assessments:
Recovery from illness: black eye disappears, and wrinkle disappears, and does not recur in the future mostly；
Effective: black eye shoals, and wrinkle shoals, and does not recur in the future mostly；
Invalid: black eye is constant, and even more seriously, wrinkle does not shoal, or even deepens.
5, test result:
The following table 2 is the crease-resistant black eye effect of dispelling of 1~embodiment of embodiment 6
Table 2
| Serial number | Number of cases | Recovery from illness/example | Effectively/example | In vain/example | Effective percentage/% |
| Embodiment 1 | 60 | 5 | 52 | 3 | 95% |
| Embodiment 2 | 60 | 12 | 45 | 3 | 95% |
| Embodiment 3 | 60 | 17 | 41 | 2 | 96.7% |
| Embodiment 4 | 60 | 22 | 36 | 2 | 96.7% |
| Embodiment 5 | 60 | 23 | 35 | 2 | 96.7% |
| Embodiment 6 | 60 | 0 | 3 | 57 | 5% |
As can be seen from the above table, 1~embodiment of the embodiment of the present invention 6 is removed without the invalid outer of addition effect object,
Remaining embodiment 1-5 dispels black eye significant effect, and effective percentage reaches 95% or more.Therefore, crease-resistant black eye eye cream of the invention, tool
Have it is excellent it is crease-resistant go black eye effect, skin lines can be improved, mitigate the effect of the skin problems such as black eye, eye pouch.
The above description is only a preferred embodiment of the present invention, is not intended to limit the scope of the invention, all utilizations
Equivalent structure transformation made by present specification is applied directly or indirectly in other relevant technical fields, same
Reason is included within the scope of the present invention.
Claims (7)
1. crease-resistant black eye eye cream is removed a kind of, which is characterized in that (water, glycerol, hard comprising the eye pouch compound HALOXYL that such as goes down
Lipidol polyethers -20, n-hydroxysuccinimide, 5,7- dihydroxyflavone, palmitoyl oligopeptide, palmityl tetrapeptide -7), purple perilla extract
Object, Argireline, 3-o- ethylascorbyl, yeast extract, silk glue protein, beta glucan and Sodium Hyaluronate.
2. crease-resistant black eye eye cream is removed according to claim 1, which is characterized in that is calculated by mass percentage, the eye
Frost comprising 0.1%-5% go eye pouch compound HALOXYL (water, glycerol, stereth -20, n-hydroxysuccinimide,
5,7- dihydroxyflavone, palmitoyl oligopeptide, palmityl tetrapeptide -7), 0.1%-5% extractive of perilla, 0.1%-5% acetyl group six
Peptide -8,0.1%-2%3-o- ethylascorbyl, 0.1%-5% yeast extract, 0.1%-5% silk glue protein,
0.02%-0.1% beta glucan and 0.02%-0.2% Sodium Hyaluronate.
3. eye cream according to claim 2, it is characterised in that: be calculated by mass percentage, the Essence includes 3%
Go eye pouch compound HALOXYL (water, glycerol, stereth -20, n-hydroxysuccinimide, 5,7- dihydroxyflavone,
Palmitoyl oligopeptide, palmityl tetrapeptide -7), 2.5% extractive of perilla, 2.5% Argireline, 1.5%3-o- ethyl it is anti-bad
Hematic acid, 2% yeast extract, 2.5% silk glue protein, 0.05% beta glucan and 0.1% Sodium Hyaluronate.
4. eye cream described in -3 any one according to claim 1, it is characterised in that: the Essence also includes moisturizer, profit
Skin agent, emulsifier, thickener, preservative, aromatic and solvent.
5. eye cream according to claim 4, it is characterised in that: the moisturizer include butanediol, 1.3- propylene glycol, gather it is sweet
Oil -10, the emollient is jojoba oil, shea butter, macadimia nut oil, emulsifier described in dimethyl silicone polymer be gather it is sweet
Oily -3 methyl distearates, the thickener are hydroxy-ethyl acrylate/sodium acryloyldimethyl taurate copolymers, institute
Stating preservative is Chlorphenesin and Phenoxyethanol, and the aromatic is attar of rose, and the solvent is deionized water.It is wanted according to right
Eye cream described in asking 4, it is characterised in that be calculated by mass percentage, the eye cream includes the moisturizer of 1%-10%, 1%-
10% emollient, 0.5%-2% emulsifier, 0.5%-2% thickener, 0.5%-1% preservative, 0.01%-0.1% fragrance
The solvent deionized water of agent and surplus.
6. eye cream according to claim 5, it is characterised in that: be calculated by mass percentage, the eye cream includes 1%-5%
Butanediol, 1%-5%1.3- propylene glycol, 1%-3% Natrulon H-10,1%-3% jojoba oil, 1%-3% shea butter,
1%-3% macadimia nut oil, 1%-3% dimethyl silicone polymer, 0.5%-2% polyglycereol-3-methyl distearate,
0,5%-2% hydroxy-ethyl acrylate/sodium acryloyldimethyl taurate copolymers, 0.1%-0.5% Chlorphenesin, 0.1%-
The deionized water of 0.5% Phenoxyethanol, 0.01%-0.1% attar of rose and surplus.
7. eye cream according to claim 6, it is characterised in that: be calculated by mass percentage, the eye cream includes 3% fourth two
Alcohol, 2%1.3- propylene glycol, 2% Natrulon H-10,1.5% jojoba oil, 1.5% shea butter, 1.5% macadimia nut oil,
1.5% dimethyl silicone polymer, 1.5% polyglycereol-3-methyl distearate, 1% hydroxy-ethyl acrylate/acryloyl two
N-methyltaurine sodium copolymer, 0.25% Chlorphenesin, 0.5% Phenoxyethanol, 0.03% attar of rose and surplus deionization
Water.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910719840.6A CN110302113A (en) | 2019-08-06 | 2019-08-06 | One kind is crease-resistant to remove black eye eye cream |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910719840.6A CN110302113A (en) | 2019-08-06 | 2019-08-06 | One kind is crease-resistant to remove black eye eye cream |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110302113A true CN110302113A (en) | 2019-10-08 |
Family
ID=68083219
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910719840.6A Pending CN110302113A (en) | 2019-08-06 | 2019-08-06 | One kind is crease-resistant to remove black eye eye cream |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110302113A (en) |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110585043A (en) * | 2019-10-09 | 2019-12-20 | 广州上官靖文化传播有限公司 | Eye cream with wrinkle eliminating function and preparation method thereof |
| CN110638707A (en) * | 2019-10-29 | 2020-01-03 | 浙江英树生物科技有限公司 | Eye care cream and preparation method thereof |
| CN110772463A (en) * | 2019-12-13 | 2020-02-11 | 广州市科能化妆品科研有限公司 | Eye skin repair composition and preparation method and application thereof |
| CN111617023A (en) * | 2020-07-14 | 2020-09-04 | 北昊干细胞与再生医学研究院有限公司 | Eye composition and preparation method thereof |
| CN112220714A (en) * | 2020-09-11 | 2021-01-15 | 广州多美生物科技有限公司 | Red ginseng vigor activating oxygen eye cream and preparation method thereof |
| CN112535653A (en) * | 2020-12-25 | 2021-03-23 | 西南林业大学 | Dendrobium officinale moisturizing and repairing essence milk and preparation method thereof |
| CN112656702A (en) * | 2021-01-11 | 2021-04-16 | 上海菩兰实业有限公司 | Application of aescin in eye cream |
| CN112675108A (en) * | 2020-12-31 | 2021-04-20 | 北京日光旭升精细化工技术研究所 | Moisturizing, relieving and anti-wrinkle eye cream and preparation method thereof |
| CN114028259A (en) * | 2020-08-11 | 2022-02-11 | 广东长昊药业股份有限公司 | Eye cream and preparation method thereof |
| CN115363986A (en) * | 2022-09-29 | 2022-11-22 | 广东丸美生物技术股份有限公司 | Skin care composition with black eye improving effect, preparation method thereof and cosmetic |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106580798A (en) * | 2016-12-30 | 2017-04-26 | 广州科盈化妆品有限公司 | All-in-one eye cream and preparation method |
| CN107929189A (en) * | 2017-12-27 | 2018-04-20 | 佛山微赢电子商务有限公司 | A kind of energy Vitamin K removes eye cream of eye circumference microgroove and preparation method thereof |
-
2019
- 2019-08-06 CN CN201910719840.6A patent/CN110302113A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106580798A (en) * | 2016-12-30 | 2017-04-26 | 广州科盈化妆品有限公司 | All-in-one eye cream and preparation method |
| CN107929189A (en) * | 2017-12-27 | 2018-04-20 | 佛山微赢电子商务有限公司 | A kind of energy Vitamin K removes eye cream of eye circumference microgroove and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| KARL LINTNER，SEDERMA SAS: "《RESEARCH DISCLOSURE》", 31 May 2005, THE INDUSTRY STANDARD DISCLOSURE PUBLICATION * |
| 王建新: "《化妆品植物原料大全》", 30 June 2012, 中国纺织出版社 * |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110585043A (en) * | 2019-10-09 | 2019-12-20 | 广州上官靖文化传播有限公司 | Eye cream with wrinkle eliminating function and preparation method thereof |
| CN110638707A (en) * | 2019-10-29 | 2020-01-03 | 浙江英树生物科技有限公司 | Eye care cream and preparation method thereof |
| CN110772463A (en) * | 2019-12-13 | 2020-02-11 | 广州市科能化妆品科研有限公司 | Eye skin repair composition and preparation method and application thereof |
| CN110772463B (en) * | 2019-12-13 | 2022-06-28 | 广州市科能化妆品科研有限公司 | Eye skin repair composition and preparation method and application thereof |
| CN111617023A (en) * | 2020-07-14 | 2020-09-04 | 北昊干细胞与再生医学研究院有限公司 | Eye composition and preparation method thereof |
| CN111617023B (en) * | 2020-07-14 | 2022-07-01 | 北昊干细胞与再生医学研究院有限公司 | Eye composition and preparation method thereof |
| CN114028259A (en) * | 2020-08-11 | 2022-02-11 | 广东长昊药业股份有限公司 | Eye cream and preparation method thereof |
| CN112220714A (en) * | 2020-09-11 | 2021-01-15 | 广州多美生物科技有限公司 | Red ginseng vigor activating oxygen eye cream and preparation method thereof |
| CN112535653A (en) * | 2020-12-25 | 2021-03-23 | 西南林业大学 | Dendrobium officinale moisturizing and repairing essence milk and preparation method thereof |
| CN112675108A (en) * | 2020-12-31 | 2021-04-20 | 北京日光旭升精细化工技术研究所 | Moisturizing, relieving and anti-wrinkle eye cream and preparation method thereof |
| CN112656702A (en) * | 2021-01-11 | 2021-04-16 | 上海菩兰实业有限公司 | Application of aescin in eye cream |
| CN115363986A (en) * | 2022-09-29 | 2022-11-22 | 广东丸美生物技术股份有限公司 | Skin care composition with black eye improving effect, preparation method thereof and cosmetic |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110302113A (en) | One kind is crease-resistant to remove black eye eye cream | |
| JP7094967B2 (en) | Extract of Anigozantos flavidas for use in cosmetics | |
| CN110522658A (en) | A kind of antiallergic remediation composition and preparation method thereof | |
| CN104856928A (en) | Anti-wrinkle and anti-aging cosmetic and preparation method thereof | |
| CN109589297A (en) | A kind of fullerene sodium hyaluronate polypeptide MASQUE APAISANT HYDRATANT | |
| CN109363976A (en) | It is a kind of to lift compact facial mask and preparation method thereof | |
| CN106535874A (en) | Pore minimizer | |
| JP6501229B2 (en) | Cosmetic composition containing brown algae extract, yeast extract and ascorbic acid | |
| JP2023052050A (en) | Use of nephelium lappaceum extract for increasing the firmness of the skin and/or of the mucous membranes | |
| CN107375148A (en) | A kind of skin repair composition | |
| CN104825804B (en) | A kind of skin whitening, moisturizing anti-apolexis composition and its production and use | |
| CN108451842B (en) | Breathable moisture mask and preparation method thereof | |
| KR20050110720A (en) | Cosmetic composition for moisturizing effect on the skin | |
| CN110693778A (en) | Face cream and production process thereof | |
| FR3003167A1 (en) | COSMETIC OR DERMATOLOGICAL COMPOSITION AND USE THEREOF | |
| US20170020805A1 (en) | Cordyceps containing topical skin care formulation | |
| CN114423400B (en) | Cosmetic composition containing graphene quantum dots as active ingredient | |
| CN113545999A (en) | Topical cosmetic composition | |
| KR20090056300A (en) | Cosmetic composition for improving the skin elasticity | |
| CN104188808B (en) | A kind of nti-freckle is dispelled yellow gel and preparation method thereof | |
| JP2012250960A (en) | Fundamental skin lotion | |
| KR102530481B1 (en) | External composition for antiaging comprising osthole | |
| CN108703917A (en) | A kind of anti-apolexis composition and its cosmetics of preparation | |
| JP7289833B2 (en) | Cosmetic use of plant Elephant extract (Phytelephas sp.) | |
| CN114652661A (en) | Liquid composition with anti-aging effect and application thereof in cosmetics |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20210705 Address after: No. 10, team 1, chabianjing village, Guiling village committee, Heyun Town, Qingxin County, Qingyuan City, Guangdong Province, 511500 Applicant after: Pan Yongkuan Address before: No.298-2, Huadu Avenue middle, Yangyi village, Shiling Town, Huadu District, Guangzhou, Guangdong 510000 Applicant before: Guangzhou Jana Biological Technology Co.,Ltd. |
|
| TA01 | Transfer of patent application right | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20191008 |
|
| RJ01 | Rejection of invention patent application after publication |